These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1134 related articles for article (PubMed ID: 28459209)
1. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway. Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209 [TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway. Zhou F; Li YH; Wang JJ; Pan J; Lu H Tumour Biol; 2017 Jun; 39(6):1010428317705748. PubMed ID: 28631572 [TBL] [Abstract][Full Text] [Related]
3. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Yu XS; Du J; Fan YJ; Liu FJ; Cao LL; Liang N; Xu DG; Zhang JD Oncotarget; 2016 Nov; 7(47):76827-76839. PubMed ID: 27765907 [TBL] [Abstract][Full Text] [Related]
4. Endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance in human ovarian cancer cells. Hu JL; Hu XL; Guo AY; Wang CJ; Wen YY; Cang SD Oncotarget; 2017 Jul; 8(30):49380-49394. PubMed ID: 28537902 [TBL] [Abstract][Full Text] [Related]
5. Effects of endoplasmic reticulum stress on autophagy and apoptosis of human leukemia cells via inhibition of the PI3K/AKT/mTOR signaling pathway. Li LJ; Chai Y; Guo XJ; Chu SL; Zhang LS Mol Med Rep; 2018 Jun; 17(6):7886-7892. PubMed ID: 29620275 [TBL] [Abstract][Full Text] [Related]
6. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A; Li H; Li R; Lu L; Wu X Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells. Ji Y; Di W; Yang Q; Lu Z; Cai W; Wu J Clin Lab; 2015; 61(8):1043-51. PubMed ID: 26427150 [TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related]
9. Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells. Yu Y; Yu X; Ma J; Tong Y; Yao J Int J Oncol; 2016 Jul; 49(1):285-93. PubMed ID: 27176231 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway. Lu PW; Li L; Wang F; Gu YT J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819 [TBL] [Abstract][Full Text] [Related]
11. Endoplasmic Reticulum Stress Promotes Autophagy and Apoptosis and Reduces Chemotherapy Resistance in Mutant p53 Lung Cancer Cells. Gan PP; Zhou YY; Zhong MZ; Peng Y; Li L; Li JH Cell Physiol Biochem; 2017; 44(1):133-151. PubMed ID: 29130967 [TBL] [Abstract][Full Text] [Related]
12. PI3K/mTOR dual inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A synergistically exert anti-tumor activity in breast cancer. Chen L; Jin T; Zhu K; Piao Y; Quan T; Quan C; Lin Z Oncotarget; 2017 Feb; 8(7):11937-11949. PubMed ID: 28060760 [TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum stress regulates proliferation, migration and invasion of human ovarian cancer SKOV3 cells through PI3K/AKT/mTOR signaling pathway. Yang N; Qu YJ; Cheng Y; Liang T; Zhang MN; Zhang D; Dong LN; Wang XW; Zhang GM Cancer Biomark; 2017 Jul; 19(3):263-269. PubMed ID: 28453460 [TBL] [Abstract][Full Text] [Related]
14. PI3K-Akt-mTOR signal inhibition affects expression of genes related to endoplasmic reticulum stress. Song Q; Han CC; Xiong XP; He F; Gan W; Wei SH; Liu HH; Li L; Xu HY Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525855 [TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation. Pang XL; He G; Liu YB; Wang Y; Zhang B World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162 [TBL] [Abstract][Full Text] [Related]
16. The PI3K/mTOR dual inhibitor P7170 demonstrates potent activity against endocrine-sensitive and endocrine-resistant ER+ breast cancer. Bean JR; Hosford SR; Symonds LK; Owens P; Dillon LM; Yang W; Shee K; Schwartz GN; Marotti JD; Muller KE; Rosenkranz KM; Barth RJ; Chen VS; Agarwal VR; Miller TW Breast Cancer Res Treat; 2015 Jan; 149(1):69-79. PubMed ID: 25491778 [TBL] [Abstract][Full Text] [Related]
17. A study on the mechanism of rapamycin mediating the sensitivity of pancreatic cancer cells to cisplatin through PI3K/AKT/mTOR signaling pathway. Li B; Yang J; Lu Z; Liu B; Liu F J BUON; 2019; 24(2):739-745. PubMed ID: 31128031 [TBL] [Abstract][Full Text] [Related]
18. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279 [TBL] [Abstract][Full Text] [Related]
19. 20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway. Zhang H; Xu HL; Wang YC; Lu ZY; Yu XF; Sui DY Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614812 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3K/Akt/mTOR signaling pathway alleviates ovarian cancer chemoresistance through reversing epithelial-mesenchymal transition and decreasing cancer stem cell marker expression. Deng J; Bai X; Feng X; Ni J; Beretov J; Graham P; Li Y BMC Cancer; 2019 Jun; 19(1):618. PubMed ID: 31234823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]